// App-Quantinova.ai

TCT-369 : Durability of Reduced Office-Measured Blood Pressure and Antihypertensive Medication Use After Ultrasound Renal Denervation: 24-Month Results From the RADIANCE-HTN SOLO Trial

Researchers

Presenter

  • Florian Rader

Principal Investigators

  • Ajay Kirtane

  • Yale Wang

  • Joost Daemen

  • Phillip Lurz

  • Jeremy Sayer

  • Manish Saxena

  • Terry Levy

  • Michel Azizi

  • Michael Weber

Medical Centers

  • AP-HP, Hôpital Européen Georges-Pompidou, Hypertension Department and DHU PARC, Paris, France

  • Essex Cardiothoracic Centre, Basildon, United Kingdom

  • Royal Bournemouth, Bournemouth, United Kingdom

  • Université Paris-Descartes, Paris, France

  • Cedars-Sinai Smidt Heart Institute, Los Angeles, California, USA

  • Minneapolis Heart Institute, Minneapolis, Minnesota, USA

  • Barts Health NHS Trust, London, United Kingdom

  • State University of New York Downstate Medical Center, New York, New York, USA

  • NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York, USA

  • Thoraxcenter Erasmus Medical Center, Rotterdam, the Netherlands

  • Heart Center Leipzig at University of Leipzig, Leipzig, Germany

Locations

  • France

  • United Kingdom

  • United States

  • Netherlands

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Rho Guanine Nucleotide Exchange Factor 40

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved